Smart Reactors

Advanced Surface Treatments for Flow Diverters: Enhancing Performance and Biocompatability

Flow diverters have transformed the treatment landscape for complex intracranial aneurysms, offering a minimally invasive alternative to traditional surgical approaches. As this technology continues to evolve, advanced surface treatments have emerged as a critical factor in enhancing both the performance and biocompatibility of these devices. This article explores the cutting-edge surface treatments that are shaping the future of flow diverter technology and their potential to revolutionize neurovascular interventions.

Surface treatments play a pivotal role in determining how flow diverters interact with the body’s complex biological systems. They significantly impact:

  1. Thrombogenicity
  2. Endothelialization rate
  3. Inflammatory response
  4. Device integration with vessel walls
  5. Corrosion resistance

Mr. Brian Haddigan, co-founder of Smart Reactors, emphasizes, “The surface of a flow diverter is the critical interface where engineering meets biology. It’s this nanoscale boundary that determines whether a device will be seamlessly accepted by the body or trigger adverse reactions.”

  1. Plasma Treatment
    • Plasma surface modification has emerged as a versatile technique for enhancing flow diverter surfaces. It can:
      • Increase surface energy and wettability, improving cellular adhesion
      • Enhance the adhesion of subsequent coatings, allowing for multi-layer functionalization
      • Create nano-textured surfaces that mimic the natural extracellular matrix, promoting better cell adhesion and proliferation
    • Recent studies have shown that oxygen plasma treatment can increase the surface roughness of nitinol flow diverters, significantly improving endothelial cell attachment.
  2. Ion Implantation
    • This advanced technique involves bombarding the surface with high-energy ions to:
      • Modify surface composition without affecting bulk properties
      • Enhance corrosion resistance, crucial for long-term implant stability
      • Improve wear resistance,
      • Research has demonstrated that nitrogen ion implantation can reduce nickel ion release from nitinol flow diverters , potentially decreasing allergic reactions and improving long-term biocompatibility.
  1. Chemical Vapor Deposition (CVD)
    • CVD techniques are being used to create thin films on flow diverter surfaces, offering:
      • Improved biocompatibility through the deposition of diamond-like carbon coatings
      • Enhanced mechanical properties, including increased flexibility and kink resistance
      • Potential for incorporating bioactive elements such as silver for antimicrobial properties
  1. Physical Vapor Deposition (PVD)
    • PVD techniques like sputtering or evaporation are increasingly utilized to:
      • Create ultra-thin, uniform coatings with thicknesses as low as 10 nm
      • Deposit a wide range of materials, including ceramics and noble metals
      • Enhance radiopacity without compromising mechanical characteristics
    • Recent developments in PVD have allowed for the creation of gradient coatings that can provide varying properties along the length of a flow diverter, optimizing performance in different vascular regions.
  1. Electrochemical Surface Treatments
    • Processes like anodization or electropolishing are being refined to:
      • Create controlled oxide layers that can modulate protein adsorption
      • Improve corrosion resistance, particularly important for long-term implantation
      • Enhance surface smoothness for better flow dynamics and reduced thrombogenicity
    • Studies have shown that electropolished flow diverters can reduce platelet adhesion compared to untreated surfaces.
  1. Laser Surface Modification
    • Cutting-edge laser treatments are being developed to:
      • Create precise micro- or nano-textures that can guide cell growth
      • Modify surface chemistry for improved biocompatibility
      • Enhance endothelial cell adhesion and proliferation through biomimetic surface patterns
    • Recent research has demonstrated that laser-textured flow diverters can achieve complete endothelialization faster than smooth surfaces.

Mark Brassil, CTO of Smart Reactors, states, “Our Camouflage™ technology integrates multiple advanced surface treatments to create a truly biomimetic interface. We’re not just preventing complications; we’re actively promoting healing and integration at the molecular level.”

  1. Enhanced Thromboresistance
    • Studies show up to 80% reduction in platelet adhesion with optimized surface treatments
    • Some advanced coatings have demonstrated the potential to eliminate the need for long-term antiplatelet therapy
  2. Accelerated Endothelialization
    • Certain surface-treated devices have shown complete endothelial coverage in as little as 30 days, compared to 3-6 months for untreated devices
    • Faster endothelialization correlates with reduced risk of thrombosis
  3. Improved Corrosion Resistance
    • Advanced surface treatments can extend the functional lifespan of flow diverters 
    • Reduced corrosion leads to decreased metal ion release, potentially lowering the risk of delayed hypersensitivity reactions
  4. Reduced Inflammatory Response
    • Some surface modifications have shown a 60% decrease in inflammatory marker expression

As the field continues to advance, several exciting developments are on the horizon:

  1. Biologically Active Surfaces
    • Incorporating growth factors or cell-signaling molecules directly into the surface layer
    • Potential for surfaces that can actively recruit endothelial progenitor cells from circulation
  2. Shape Memory Surfaces
    • Developing surfaces that can change properties in response to temperature or other stimuli
    • Possibility of flow diverters that can adapt their porosity post-implantation
  3. Self-Healing Surfaces
    • Creating surfaces that can repair minor damage or wear over time
    • Potential to significantly extend the functional lifespan of implanted devices
  4. Nanostructured Hierarchical Surfaces
    • Designing multi-scale surface textures that mimic natural vascular structures
    • Aim to achieve perfect biomimicry for optimal integration with host tissue
  5. Electrically Active Surfaces
    • Developing surfaces that can modulate local electrical fields to influence cell behavior
    • Potential for “smart” flow diverters that can actively control the local cellular environment

Advanced surface treatments are at the forefront of flow diverter innovation, offering unprecedented control over device-tissue interactions. By fine-tuning surface properties at the nano- and micro-scale, we can create flow diverters that not only divert blood flow but actively participate in the healing process.

At Smart Reactors, we are pioneering the next generation of surface treatments for flow diverters. Our Camouflage™ technology platform represents a holistic approach to surface engineering, combining multiple advanced treatments to create truly biomimetic surfaces that can adapt to the complex neurovascular environment.

As we look to the future, the potential for surface-treated flow diverters to improve patient outcomes is immense. We anticipate continued breakthroughs in this field, leading to devices with enhanced safety profiles, improved long-term efficacy, and the ability to treat an even wider range of complex aneurysms.

By pushing the boundaries of surface science and bioengineering, we are not just creating better medical devices; we are paving the way for a new paradigm in neurovascular intervention where the line between artificial implant and natural tissue becomes increasingly blurred. The future of aneurysm treatment lies in these advanced surface technologies, promising safer, more effective, and potentially curative interventions for patients worldwide.

Chen, Y., et al. (2020). “Surface modification of implantable biomaterials for vascular applications: A review.” Acta Biomaterialia, 108, 1-22.

Maegawa, J., et al. (2019). “Surface modification of neurovascular devices for improved biocompatibility: A systematic review.” Journal of NeuroInterventional Surgery, 11(11), 1047-1052.

Ding, Y., et al. (2018). “Plasma-treated flow diverters: A new frontier in neurovascular intervention.” ACS Applied Materials & Interfaces, 10(25), 21334-21342.

Szikora, I., et al. (2019). “The impact of surface modification on the biocompatibility of flow diverter stents.” Interventional Neuroradiology, 25(3), 279-285.

Food and Drug Administration. (2021). “Neurological Devices; Reclassification of Certain Flow Diverter Devices for the Treatment of Brain Aneurysms.” Federal Register, 86(71), 19785-19792.